$1.62
0.149.46%
At close: -
$1.62
-0.00050-0.03%
After Hours: Dec 20, 4:29 PM EDT
ALX Oncology Holdings reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ALX Oncology Holdings using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.45 | $-0.78 | 42.3 % |
Jun 2024 | 2024-08-08 | $-0.62 | $-0.77 | 19.5 % |
Mar 2024 | 2024-05-09 | $-0.57 | $-0.84 | 32.1 % |
Dec 2023 | 2024-03-07 | $-0.79 | $-0.86 | 8.14 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2020 | 2020-11-12 | $0 | $570.00K | -100.0 % |
Jun 2020 | 2020-08-27 | $527.00K | $750.00K | -29.7 % |
ALX Oncology Holdings (ALXO) is scheduled to report earnings on March 6, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.45, which beat the estimate of $-0.78.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.